Cat.#: BBM-3C-093
Description | 3D Cell and Organoid Culturing Gel Kit is constructed with synthetic biological raw materials to simulate the microenvironment of human tissue. It has stable quality and freely adjustable colloid hardness, easy operation, high culture stability, high cell recovery rate, and high biocompatibility. |
Unit | 1 kit |
Components | BBM-3C-093-A, 3D Culturing Gel (2X), 0.5 mL BBM-3C-093-B, Covering Buffer(10X), 12.5 mL BBM-3C-093-C, Dissociating Buffer(10X), 12.5 mL |
Size | 480 assays, 240 assays, 120 assasys |
Storage | 2-8 ℃ |
Shipping | Blue ice |
Applications | Used for 3D cell and organoid culture. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-090 | 3D 10x CB-Buffer (pH 5.5) |
3D 10x CB-Buffer (pH 5.5), a buffer solution, provides a cell environment at pH 5.5 for the formation of fast-gelling 3D hydrogels.
|
inquiry |
BBM-3C-086 | 3D SG-Dextran |
3D SG-Dextran consists of dextran functionalized with thiol-reactive groups (SG-Dextran), which can be used together with other components PEG-Link or CD-Link to set up cell-compatible hydrogels.
|
inquiry |
BBM-3C-112 | 3D RGD-CD Hydrogel Kits |
3D Hydrogel Kits (Pre-Configured), a pre-configured 3D hydrogel system, consists of RGD (arginyl glycyl aspartate) degradable polymer and CD cell degradable cross-linking agent. When RGD and CD cross-linkers are mixed, they cross-link into a gel.
|
inquiry |
BBM-3C-115 | 3D Cell Culture Hydrogel Matrix |
3D Cell Culture Hydrogel Matrix is a ready-to-use, xeno-free (animal source-free) functional hydrogel for 3D cell culture research.
|
inquiry |
BBM-3C-072 | Ready-to-use 3D Hydrogel kit |
Ready-to-Use 3D Hydrogel Kit is a set of reagents for constructing extracellular matrix components in 3D cell culture, and is similar to a living extracellular matrix. The kits contain reagents for the preparation of hydrogels with a soft stiffness and an RGD peptide concentration of 0.4 mmol/L. You can use these reagents to control the extracellular environment and design 3D systems suitable for cell survival.
|
inquiry |
BBM-3C-082 | 3D PVA-HA Hydrogel Kit |
3D PVA-HA Hydrogel Kit contains the necessary reagents for creating hydrogels containing hyaluronic acid, which are SG-PVA and HyLink, a thiol-functionalized hyaluronic acid crosslinker. The formation of a gel through the stable bonding of thiol groups on HyLink with thiol-reactive groups on SG-PVA, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
BBM-3C-085 | 3D HyLink |
3D HyLink molecule consists of hyaluronic acid carrying thiol groups along its backbone. When combined with polymers SG-PVA and SG-Dextran, thiol groups on HyLink form stable thioether bonds with the thiol-reactive groups on the polymers, which results in the formation of the hydrogel.
|
inquiry |
BBM-3C-073 | 3D F-Dextran-PEG Hydrogel Kit |
3D Dextran-PEG Hydroge Kit contains the necessary reagents for creating hydrogels that gel fast and are compatible with living cells, which are maleimide functionalized dextran (Mal-Dextran), and PEG-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on PEG-Link with maleimide groups on the Mal-Dextran, when the two reagents are combined.
|
inquiry |
BBM-3C-084 | 3D CD-Link |
When the 3D CD-Link molecule, which is made up of a polyethylene glycol-peptide conjugate with thiol groups on both ends, is mixed with polymers Mal-PVA, Mal-Dextran, SG-PVA, and SG-Dextran, the thiol groups on CD-Link react with thiol-reactive groups on the polymers, forming stable thioether bonds, thus leading to the creation of the hydrogel.
|
inquiry |
BBM-3C-118 | 3D Stem Hydrogel |
3D Stem Hydrogel is a ready-to-use hydrogel system for the three-dimensional (3D) mesenchymal stem cells culture. It is animal-free and can be used directly with cells for 3D culture or to generate hydrogel cell beads.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.